ASX:CUVBiotechs
Is Clinuvel (ASX:CUV) Using Its Singapore Peptide Hub To Quietly Redefine Its Pipeline Ambitions?
Clinuvel Pharmaceuticals has recently expanded its Vallaurix research, development, and innovation hub in Singapore, backed by the Singapore Economic Development Board, to build a global center for advanced, long-acting peptide therapies and integrated formulation and analytical sciences.
This move strengthens Clinuvel’s push toward greater vertical integration in peptide-based medicine, aiming to speed up late-stage development programs and broaden its pipeline beyond a single flagship...